Use of peak expiratory flow for assessing bronchodilator responsiveness

Primary Care Respiratory Journal

Volumn 18, Issue 1, 2009, Pages 50-52

  Aggarwal, Ashutosh N ^a   Agarwal, Ritesh ^a   Gupta, Dheeraj ^a   Jindal, Surinder K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Assessment; Bronchodilator responsiveness; Lung function; Peak expiratory flow; Spirometry

Indexed keywords

SALBUTAMOL;

ADOLESCENT; ADULT; AGED; ARTICLE; DRUG RESPONSE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PREDICTION AND FORECASTING; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRONCHODILATOR AGENTS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PEAK EXPIRATORY FLOW RATE; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; YOUNG ADULT;

EID: 62749127096     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.3132/pcrj.2008.00064     Document Type: Article

References (11)

1. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144:1202-18.
2. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948-68.
3. National Institutes of Health, National Heart Lung and Blood Institute. Update of the NHLBI/WHO Workshop Report: Global Strategy for Asthma Management and Prevention. Issued January 1995. Global Initiative for Asthma. Bethesda: National Institutes of Health, National Heart Lung and Blood Institute; Revised 2002. Document No. 02-3659, 2002.
4. British Thoracic Society, Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma. Thorax 2003;58 Suppl 1:i1-94.
5. Aggarwal AN, Gupta D, Jindal SK. The relationship between FEV1 and peak expiratory flow in patients with airways obstruction is poor. Chest 2006;130:1454-61.
6. Dekker FW, Schrier AC, Sterk PJ, Dijkman JH. Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction. Thorax 1992;47:162-6.
7. Pino JM, Garcia-Rio F, Prados C, et al. Value of the peak expiratory flow in bronchodynamic tests. Allergol Immunopathol (Madr) 1996;24:54-7.
8. Thiadens HA, De Bock GH, Van Houwelingen JC, et al. Can peak expiratory flow measurements reliably identify the presence of airway obstruction and bronchodilator response as assessed by FEV1 in primary care patients presenting with a persistent cough? Thorax 1999;54:1055- 60.
9. Slieker MG, van der Ent CK. The diagnostic and screening capacities of peak expiratory flow measurements in the assessment of airway obstruction and bronchodilator response in children with asthma. Monaldi Arch Chest Dis 2003;59:155-9.
10. American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 1995;152:1107-36.
11. Miller MR. Peak expiratory flow meter scale changes: implications for patients and health professionals. The Airways Journal 2004;2:80-2.